Skip to main content
. 2022 Feb 15;17:355–370. doi: 10.2147/COPD.S342357

Table 2.

Hazard ratios for time-to-event uutcomes for new users of fine-particle fixed dose fluticasone and extra fine fixed dose beclometasone in propensity score matched samples

Outcome Number of Patients Number of Patients with ≥ 1 Event (%) HR 95% CI p-value
Primary outcomes
Sensitive pneumonia definition
 Unmatched 20,048 584 (2.9%) 1.41 1.20–1.66 P < 0.001
 Propensity score matched 13,316 399 (3.0%) 1.38 1.14–1.68 P = 0.001
Specific pneumonia definition
 Unmatched 20,048 471 (2.3%) 1.30 1.09–1.56 P = 0.004
 Propensity score matched 13,316 322 (2.4%) 1.31 1.05–1.62 P = 0.015
Secondary outcomes
Respiratory outcome
URTI & LRTI
 Unmatched 20,048 5327 (26.6%) 1.09 1.03–1.15 P = 0.002
 Propensity score matched 13,316 3535 (26.8%) 1.08 1.01–1.16 P = 0.019
LRTI only
 Unmatched 20,048 4817 (24.1%) 1.09 1.03–1.15 P = 0.004
 Propensity score matched 13,316 3200 (24.3%) 1.08 1.01–1.15 P = 0.036
Exploratory outcomes
Acute OCS use
 Unmatched 20,048 7099 (35.5%) 1.06 1.01–1.11 P = 0.023
 Propensity score matched 13,316 4795 (36.1%) 1.04 0.98–1.10 P = 0.178
Antibiotic prescription
 Unmatched 20,048 6502 (32.5%) 1.08 1.03–1.13 P = 0.003
 Propensity score matched 13,316 4351 (32.8%) 1.03 0.97–1.10 P = 0.294
Exacerbation
 Unmatched 20,048 8998 (45.1%) 1.09 1.05–1.14 P<0.001
 Propensity score matched 13,316 6042 (45.5%) 1.06 1.01–1.11 P=0.028
Primary care recorded hospitalization
 Unmatched 20,048 6567 (32.5%) 0.98 0.94–1.03 P = 0.445
 Propensity score matched 13,316 4459 (33.9%) 1.02 0.96–1.08 P = 0.493
Pneumonia related hospitalization
 Unmatched 20,048 302 (2.5%) 1.41 1.12–1.77 P = 0.003
 Propensity score matched 13,316 223 (1.7%) 1.44 1.11–1.88 P = 0.007

Abbreviations: CI, confidence interval; HR, hazard ratio; LTRI, Lower Tract Respiratory Infection; OCS, oral corticosteroids; UTRI, Upper Tract Respiratory Infection.